WorldQuant Millennium Advisors’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.64M Buy
204,152
+9,442
+5% +$169K 0.01% 439
2026
Q1
$3.48M Buy
194,710
+5,849
+3% +$128K 0.01% 368
2025
Q4
$5.1M Buy
188,861
+178,769
+1,771% +$5.03M 0.02% 330
2025
Q3
$305K Buy
+10,092
New +$322K ﹤0.01% 477

Other funds holding CAI

WorldQuant Millennium Advisors's CAI Position: Q2 2026 in Review

WorldQuant Millennium Advisors increased its Caris Life Sciences (CAI) stake by 4.8% in Q2 2026, buying an estimated $169K and bringing the position to 204,152 shares worth $3.64M. The position accounts for 0.01% of the portfolio, ranked #439.

WorldQuant Millennium Advisors first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.1M in Q4 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • WorldQuant Millennium Advisors held 204,152 shares of Caris Life Sciences worth $3.64M as of Q2 2026.
  • WorldQuant Millennium Advisors bought 9,442 Caris Life Sciences shares in Q2 2026, an estimated $169K.
  • Caris Life Sciences made up 0.01% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #439 holding.
  • WorldQuant Millennium Advisors first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • WorldQuant Millennium Advisors's Caris Life Sciences position peaked at $5.1M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.